Home Hepatitis Viral hepatitis and pregnancy | Nature Reviews Gastroenterology & Hepatology

Viral hepatitis and pregnancy | Nature Reviews Gastroenterology & Hepatology

Credits to the Source Link Daniel
Viral hepatitis and pregnancy | Nature Reviews Gastroenterology & Hepatology
  • 1.

    World Health Organization. Global hepatitis report, 2017 (WHO, 2017).

  • 2.

    Jacobsen, K. H. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review (WHO, 2008).

  • 3.

    Jacobsen, K. H. Globalization and the changing epidemiology of hepatitis a virus. Cold Spring Harb. Perspect. Med. 8, a031716 (2018).

    PubMed 
    Article 

    Google Scholar
     

  • 4.

    Cho, G. J. et al. Hepatitis A virus infection during pregnancy in Korea: hepatitis A infection on pregnant women. Obstet. Gynecol. Sci. 56, 368–374 (2013).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 5.

    Elinav, E. et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 130, 1129–1134 (2006).

    PubMed 
    Article 

    Google Scholar
     

  • 6.

    Chaudhry, S. A. & Koren, G. Hepatitis A infection during pregnancy. Can. Fam. Physician 61, 963–964 (2015).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 7.

    Simsek, Y. et al. Fulminant hepatitis A infection in second trimester of pregnancy requiring living-donor liver transplantation. J. Obstet. Gynaecol. Res. 38, 745–748 (2012).

    PubMed 
    Article 

    Google Scholar
     

  • 8.

    Casey, L. C. et al. Acute liver failure (ALF) in pregnancy: how much is pregnancy-related? Hepatology https://doi.org/10.1002/hep.31144 (2020).

  • 9.

    Leikin, E. et al. Intrauterine transmission of hepatitis A virus. Obstet. Gynecol. 88, 690–691 (1996).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 10.

    Jiang, W. et al. Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system. Antivir. Res. 154, 51–57 (2018).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 11.

    Advisory Committee on Immunization Practices, Fiore, A. E., Wasley, A. & Bell, B. P. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 55, 1–23 (2006).


    Google Scholar
     

  • 12.

    Moro, P. L. et al. Reports to the vaccine adverse event reporting system after hepatitis a and hepatitis AB vaccines in pregnant women. Am. J. Obstet. Gynecol. 210, 561.e1–561.e6 (2014).

    CAS 
    Article 

    Google Scholar
     

  • 13.

    Groom, H. C. et al. Uptake and safety of hepatitis A vaccination during pregnancy: a vaccine safety datalink study. Vaccine 37, 6648–6655 (2019).

    PubMed 
    Article 

    Google Scholar
     

  • 14.

    Revill, P. A. et al. The evolution and clinical impact of hepatitis B virus genome diversity. Nat. Rev. Gastroenterol. Hepatol. 17, 618–634 (2020).

    PubMed 
    Article 

    Google Scholar
     

  • 15.

    MacLachlan, J. H. & Cowie, B. C. Hepatitis B virus epidemiology. Cold Spring Harb. Perspect. Med. 5, a021410 (2015).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • 16.

    Edmunds, W. J. et al. The influence of age on the development of the hepatitis B carrier state. Proc. R. Soc. Lond. B 253, 197–201 (1993).

    CAS 
    Article 

    Google Scholar
     

  • 17.

    Beasley, R. P. et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet 2, 388–393 (1981).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 18.

    Hu, Y. C. et al. Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program. PeerJ 6, e4297 (2018).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 19.

    Hofstraat, S. H. I. et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol. Infect. 145, 2873–2885 (2017).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 20.

    Su, W. J. et al. The impact of universal infant hepatitis B immunization on reducing the hepatitis B carrier rate in pregnant women. J. Infect. Dis. 220, 1118–1126 (2019).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 21.

    Walker, T. Y. et al. Characteristics of pregnant women with hepatitis B virus infection in 5 US public health jurisdictions, 2008-2012. Public Health Rep. 131, 685–694 (2016).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 22.

    Shepard, C. W. et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 28, 112–125 (2006).

    PubMed 
    Article 

    Google Scholar
     

  • 23.

    US Department of Health and Human Services. Hepatitis B basic information. HHS.gov https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-b-basics/index.html (2019).

  • 24.

    Goldstein, S. T. et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int. J. Epidemiol. 34, 1329–1339 (2005).

    PubMed 
    Article 

    Google Scholar
     

  • 25.

    Torimiro, J. N. et al. Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy. BMC Pregnancy Childbirth 18, 504 (2018).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 26.

    Liu, J. et al. Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study. Lancet Glob. Health 5, e624–e632 (2017).

    PubMed 
    Article 

    Google Scholar
     

  • 27.

    Ma, X. et al. Chronic hepatitis B virus infection and preterm labor(birth) in pregnant women–an updated systematic review and meta-analysis. J. Med. Virol. 90, 93–100 (2018).

    PubMed 
    Article 

    Google Scholar
     

  • 28.

    Tse, K. Y., Ho, L. F. & Lao, T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J. Hepatol. 43, 771–775 (2005).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 29.

    Tan, J. et al. Hepatitis B surface antigen positivity during pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis. J. Viral Hepat. 25, 1372–1383 (2018).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 30.

    Han, Y.-T. et al. Clinical features and outcome of acute hepatitis B in pregnancy. BMC Infect. Dis. 14, 368 (2014).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 31.

    Kimmich, N. et al. Liver transplantation during pregnancy for acute liver failure due to HBV infection: a case report. Case Rep. Obstet. Gynecol. 2013, 356560 (2013).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 32.

    Bzowej, N. H. et al. Total alanine aminotransferase (ALT) flares in pregnant North American women with chronic hepatitis B infection: results from a prospective observational study. Am. J. Gastroenterol. 114, 1283–1291 (2019).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 33.

    Liu, J. et al. Kinetic changes of viremia and viral antigens of hepatitis B virus during and after pregnancy. Medicine 94, e2001 (2015).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 34.

    Soderstrom, A., Norkrans, G. & Lindh, M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand. J. Infect. Dis. 35, 814–819 (2003).

    PubMed 
    Article 
    CAS 

    Google Scholar
     

  • 35.

    ter Borg, M. J. et al. Exacerbation of chronic hepatitis B infection after delivery. J. Viral Hepat. 15, 37–41 (2008).

    PubMed 

    Google Scholar
     

  • 36.

    Lin, H. H. et al. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers. J. Med. Virol. 29, 1–6 (1989).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 37.

    Joshi, S. S. et al. Peripartum cytokine flares in a multiethnic cohort of chronic hepatitis B carriers does not correlate with hepatitis B virus suppression or increased risk of liver disease. Am. J. Reprod. Immunol. 78, e12707 (2017).

    Article 
    CAS 

    Google Scholar
     

  • 38.

    Nguyen, V. et al. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Aliment. Pharmacol. Ther. 39, 1225–1234 (2014).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 39.

    Kushner, T. et al. Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: a regional hospital-based cohort study. Liver Int. 38, 813–820 (2018).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 40.

    Pan, C. Q. et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N. Engl. J. Med. 374, 2324–2334 (2016).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 41.

    Greenup, A. J. et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J. Hepatol. 61, 502–507 (2014).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 42.

    Jourdain, G. et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N. Engl. J. Med. 378, 911–923 (2018).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 43.

    Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67, 1560–1599 (2018).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 44.

    Giles, M. et al. Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B. Gut 64, 1810–1815 (2015).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 45.

    Liu, J. et al. Baseline hepatitis B virus titer predicts initial postpartum hepatic flare: a multicenter prospective study. J. Clin. Gastroenterol. 52, 902–907 (2017).

    Article 

    Google Scholar
     

  • 46.

    Funk, A. et al. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30586-7 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 47.

    Brown, R. S. Jr et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology 63, 319–333 (2016).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 48.

    Liu, J. et al. Presence of hepatitis B virus markers in umbilical cord blood: exposure to or infection with the virus? Dig. Liver Dis. 51, 864–869 (2019).

    PubMed 
    Article 
    CAS 

    Google Scholar
     

  • 49.

    Mavilia, M. G. & Wu, G. Y. Mechanisms and prevention of vertical transmission in chronic viral hepatitis. J. Clin. Transl. Hepatol. 5, 119–129 (2017).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 50.

    Ali, B. A. et al. Expression of hepatitis B virus genes in early embryonic cells originated from hamster ova and human spermatozoa transfected with the complete viral genome. Asian J. Androl. 8, 273–279 (2006).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 51.

    Nie, R. et al. Presence of hepatitis B virus in oocytes and embryos: a risk of hepatitis B virus transmission during in vitro fertilization. Fertil. Steril. 95, 1667–1671 (2011).

    PubMed 
    Article 

    Google Scholar
     

  • 52.

    Hu, X. L. et al. The presence and expression of the hepatitis B virus in human oocytes and embryos. Hum. Reprod. 26, 1860–1867 (2011).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 53.

    WHO Publication. Hepatitis B vaccines: WHO position paper — recommendations. Vaccine 28, 589–590 (2010).

    Article 

    Google Scholar
     

  • 54.

    Centers for Disease Control and Prevention. Perinatal transmission. CDC https://www.cdc.gov/hepatitis/hbv/perinatalxmtn.htm (2020).

  • 55.

    Amini, A. et al. Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis. BMC Infect. Dis. 17, 698 (2017).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • 56.

    Cheung, K. W. et al. Optimal timing of hepatitis B virus DNA quantification and clinical predictors for higher viral load during pregnancy. Acta Obstet. Gynecol. Scand. 98, 1301–1306 (2019).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 57.

    Wen, W. H. et al. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection. Hepatology 64, 1451–1461 (2016).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 58.

    Samadi Kochaksaraei, G. et al. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk. Liver Int. 36, 1604–1610 (2016).

    PubMed 
    Article 

    Google Scholar
     

  • 59.

    Thilakanathan, C. et al. Mother-to-child transmission of hepatitis B: examining viral cut-offs, maternal HBsAg serology and infant testing. Liver Int. 38, 1212–1219 (2018).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 60.

    Cheung, K. W. et al. The effect of rupture of membranes and labour on the risk of hepatitis B vertical transmission: prospective multicentre observational study. Eur. J. Obstet. Gynecol. Reprod. Biol. 232, 97–100 (2019).

    PubMed 
    Article 

    Google Scholar
     

  • 61.

    Han, Z. et al. Mother-to-child transmission of hepatitis B virus after amniocentesis: a retrospective matched cohort study. Prenat. Diagn. 39, 431–440 (2019).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 62.

    Yi, W. et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J. Hepatol. 60, 523–529 (2014).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 63.

    Xu, D. Z. et al. Role of placental tissues in the intrauterine transmission of hepatitis B virus. Am. J. Obstet. Gynecol. 185, 981–987 (2001).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 64.

    Mackie, F. L. et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG 124, 32–46 (2017).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 65.

    Yang, M. et al. Cesarean section to prevent mother-to-child transmission of hepatitis B virus in China: a meta-analysis. BMC Pregnancy Childbirth 17, 303 (2017).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 66.

    Dunkelberg, J. C. et al. Hepatitis B and C in pregnancy: a review and recommendations for care. J. Perinatol. 34, 882–891 (2014).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 67.

    Stevens, C. E. et al. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J. Med. Virol. 3, 237–241 (1979).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 68.

    Zou, H. et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J. Viral Hepat. 19, e18–e25 (2012).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 69.

    Wen, W. H. et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J. Hepatol. 59, 24–30 (2013).

    PubMed 
    Article 

    Google Scholar
     

  • 70.

    Cheung, K. W. et al. Immunoprophylaxis failure of infants born to hepatitis B carrier mothers following routine vaccination. Clin. Gastroenterol. Hepatol. 16, 144–145 (2018).

    PubMed 
    Article 

    Google Scholar
     

  • 71.

    Wiseman, E. et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med. J. Aust. 190, 489–492 (2009).

    PubMed 
    Article 

    Google Scholar
     

  • 72.

    Benhammou, V. et al. HBV or HCV coinfection in HIV-1-infected pregnant women in France: prevalence and pregnancy outcomes. J. Acquir. Immune Defic. Syndr. 77, 439–450 (2018).

    PubMed 
    Article 

    Google Scholar
     

  • 73.

    Mave, V. et al. Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV. HIV. Med. 15, 347–354 (2014).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 74.

    Chotun, N. et al. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. Vaccine 33, 4618–4622 (2015).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 75.

    Vanclaire, J., Cornu, C. & Sokal, E. M. Fulminant hepatitis B in an infant born to a hepatitis Be antibody positive, DNA negative carrier. Arch. Dis. Child. 66, 983–985 (1991).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 76.

    Delaplane, D. et al. Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics 72, 176–180 (1983).

    CAS 
    PubMed 

    Google Scholar
     

  • 77.

    Sacher, M., Unger, F. D. & Eder, G. Vertical hepatitis B transmission by anti-HBe positive hepatitis B carrier mothers. Padiatr. Padol. 21, 141–146 (1986).

    CAS 
    PubMed 

    Google Scholar
     

  • 78.

    Bahn, A. et al. Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants. J. Med. Virol. 47, 336–341 (1995).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 79.

    Schaefer, E., Koeppen, H. & Wirth, S. Low level virus replication in infants with vertically transmitted fulminant hepatitis and their anti-HBe positive mothers. Eur. J. Pediatr. 152, 581–584 (1993).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 80.

    Chen, H. L. et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 39, 58–63 (2004).

    PubMed 
    Article 

    Google Scholar
     

  • 81.

    Bigna, J. J. et al. Gender development and hepatitis B and C infections among pregnant women in Africa: a systematic review and meta-analysis. Infect. Dis. Poverty 8, 16 (2019).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 82.

    Wang, Y. et al. Prevalence of chronic hepatitis B and status of HBV care among rural women who planned to conceive in China. Sci. Rep. 7, 12090 (2017).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • 83.

    Segeral, O. et al. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study. J. Clin. Virol. 109, 29–34 (2018).

    PubMed 
    Article 

    Google Scholar
     

  • 84.

    Cornberg, M. et al. The role of quantitative hepatitis B surface antigen revisited. J. Hepatol. 66, 398–411 (2017).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 85.

    European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol. 67, 370–398 (2017).

    Article 

    Google Scholar
     

  • 86.

    Fujiko, M. et al. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction? Int. J. Infect. Dis. 41, 83–89 (2015).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 87.

    Sun, K. X. et al. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. Vaccine 30, 5335–5340 (2012).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 88.

    Patel, N. H. et al. Analysis of serum hepatitis B virus RNA levels in a multiethnic cohort of pregnant chronic hepatitis B carriers. J. Clin. Virol. 111, 42–47 (2019).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 89.

    Shimakawa, Y. et al. Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa. Clin. Infect. Dis. 70, 1442–1452 (2019).


    Google Scholar
     

  • 90.

    Wang, C. et al. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure. Medicine 95, e4390 (2016).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 91.

    Kang, W. et al. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province, China. Vaccine 32, 3362–3366 (2014).

    PubMed 
    Article 

    Google Scholar
     

  • 92.

    Isaacs, D. et al. Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation. Vaccine 29, 6159–6162 (2011).

    PubMed 
    Article 

    Google Scholar
     

  • 93.

    Eke, A. C. et al. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Cochrane Database Syst. Rev. 2, CD008545 (2017).

    PubMed 

    Google Scholar
     

  • 94.

    Childs, L., Roesel, S. & Tohme, R. A. Status and progress of hepatitis B control through vaccination in the South-East Asia region, 1992-2015. Vaccine 36, 6–14 (2018).

    PubMed 
    Article 

    Google Scholar
     

  • 95.

    Breakwell, L. et al. The status of hepatitis B control in the African region. Pan Afr. Med. J. 27, 17 (2017).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 96.

    Wiesen, E., Diorditsa, S. & Li, X. Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990–2014. Vaccine 34, 2855–2862 (2016).

    PubMed 
    Article 

    Google Scholar
     

  • 97.

    Cui, F. et al. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation. Vaccine 31, J36–J42 (2013).

    PubMed 
    Article 

    Google Scholar
     

  • 98.

    Xeuatvongsa, A. et al. Improving hepatitis B birth dose in rural Lao People’s Democratic Republic through the use of mobile phones to facilitate communication. Vaccine 34, 5777–5784 (2016).

    PubMed 
    Article 

    Google Scholar
     

  • 99.

    World Health Organization. A systematic review of monovalent hepatitis B vaccine thermostability (WHO, 2016).

  • 100.

    Wait, S. et al. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments. Lancet Gastroenterol. Hepatol. 1, 248–255 (2016).

    PubMed 
    Article 

    Google Scholar
     

  • 101.

    Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral pregnancy registry interim report for 1 January 1989 through 31 January 2020 (Registry Coordinating Center, 2020).

  • 102.

    Ayres, A. et al. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations. J. Viral Hepat. 21, 809–817 (2014).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 103.

    Hu, Y. H. et al. Tenofovir rescue therapy in pregnant females with chronic hepatitis B. World J. Gastroenterol. 21, 2504–2509 (2015).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 104.

    World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection (WHO, 2015).

  • 105.

    Shyamala, V. et al. Assessment of the target-capture PCR hepatitis B virus (HBV) DNA quantitative assay and comparison with commercial HBV DNA quantitative assays. J. Clin. Microbiol. 42, 5199–5204 (2004).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 106.

    Han, G. R. et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J. Hepatol. 55, 1215–1221 (2011).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 107.

    Sarin, S. K. et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol. Int. 10, 1–98 (2016).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 108.

    Shi, Z. et al. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch. Pediatr. Adolesc. Med. 165, 837–846 (2011).

    PubMed 
    Article 

    Google Scholar
     

  • 109.

    Zheng, Y. et al. Should chronic hepatitis B mothers breastfeed? A meta analysis. BMC Public Health 11, 502 (2011).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 110.

    World Health Organization. Hepatitis B and breastfeeding (WHO, 1996).

  • 111.

    Hu, X., Wang, L. & Xu, F. Guides concerning tenofovir exposure via breastfeeding: a comparison of drug dosages by developmental stage. Int. J. Infect. Dis. 87, 8–12 (2019).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 112.

    Benaboud, S. et al. Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d’Ivoire, in the ANRS 12109 TEmAA Study, Step 2. Antimicrob. Agents Chemother. 55, 1315–1317 (2011).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 113.

    Grant, P. M. & Cotter, A. G. Tenofovir and bone health. Curr. Opin. HIV AIDS 11, 326–332 (2016).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 114.

    Schillie, S. et al. Update: Shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers. Morb. Mortal. Wkly. Rep. 64, 1118–1120 (2015).

    Article 

    Google Scholar
     

  • 115.

    Indolfi, G. et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol. Hepatol. 4, 466–476 (2019).

    PubMed 
    Article 

    Google Scholar
     

  • 116.

    Woodring, J. et al. Integrating HIV, hepatitis B and syphilis screening and treatment through the Maternal, Newborn and Child Health platform to reach global elimination targets. West. Pac. Surveill. Response J. 8, 1–5 (2017).

    Article 

    Google Scholar
     

  • 117.

    Gavi. Gavi Alliance Programme and Policy Committee meeting 23–24 October 2019 (Gavi, 2019).

  • 118.

    World Health Organization. Guidelines on hepatitis B and C testing (WHO, 2016).

  • 119.

    Jing, W. et al. Cost-effectiveness of couple-based immunization strategy to prevent mother-to-child transmission of hepatitis B virus in China: a decision-analytic Markov model. EClinicalMedicine 19, 100264 (2020).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 120.

    Rajbhandari, R. et al. Discontinuity of care for mothers with chronic hepatitis B diagnosed during pregnancy. J. Viral Hepat. 23, 561–568 (2016).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 121.

    Cheung, K. W. et al. Pattern and predictors of medical care received by hepatitis B carriers during pregnancy and after delivery. Public Health 168, 36–42 (2019).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 122.

    Davis, C. et al. Highly diverse hepatitis C strains detected in sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments. Hepatology 69, 1426–1441 (2019).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 123.

    Bialek, S. R. & Terrault, N. A. The changing epidemiology and natural history of hepatitis C virus infection. Clin. Liver Dis. 10, 697–715 (2006).

    PubMed 
    Article 

    Google Scholar
     

  • 124.

    Wei, L. & Huang, Y. H. Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents. Expert Rev. Anti Infect. Ther. 17, 311–325 (2019).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 125.

    Petruzziello, A. et al. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J. Gastroenterol. 22, 7824–7840 (2016).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 126.

    DeMaria, A. Jr Hearing from the silent epidemic. Ann. Intern. Med. 166, 846–847 (2017).

    PubMed 
    Article 

    Google Scholar
     

  • 127.

    Gower, E. et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 61, S45–S57 (2014).

    PubMed 
    Article 

    Google Scholar
     

  • 128.

    Onofrey, S. et al. Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002-2009. Morb. Mortal. Wkly. Rep. 60, 537–541 (2011).


    Google Scholar
     

  • 129.

    Ly, K. N. et al. Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014. Ann. Intern. Med. 166, 775–782 (2017).

    PubMed 
    Article 

    Google Scholar
     

  • 130.

    American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C (AASLD/IDSA, 2020).

  • 131.

    Chaillon, A. et al. Cost-effectiveness of universal hepatitis C virus screening of pregnant women in the United States. Clin. Infect. Dis. 69, 1888–1895 (2019).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 132.

    US Preventive Services Task Force et al. Screening for hepatitis C virus infection in adolescents and adults: US preventive services task force recommendation statement. JAMA 323, 970–975 (2020).

    Article 

    Google Scholar
     

  • 133.

    Waruingi, W. et al. Hepatitis C virus universal screening versus risk based selective screening during pregnancy. J. Neonatal Perinat. Med. 8, 371–378 (2015).

    CAS 
    Article 

    Google Scholar
     

  • 134.

    El-Kamary, S. S. et al. Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt. J. Infect. 70, 512–519 (2015).

    PubMed 
    Article 

    Google Scholar
     

  • 135.

    Chibber, R., El-Saleh, E. & El Harmi, J. Female circumcision: obstetrical and psychological sequelae continues unabated in the 21st century. J. Matern. Fetal Neonatal Med. 24, 833–836 (2011).

    PubMed 
    Article 

    Google Scholar
     

  • 136.

    Society for Maternal-Fetal Medicine, Hughes, B. L., Page, C. M. & Kuller, J. A. Hepatitis C in pregnancy: screening, treatment, and management. Am. J. Obstet. Gynecol. 217, B2–B12 (2017).


    Google Scholar
     

  • 137.

    Kaberg, M. & Weiland, O. Hepatitis C elimination – macro-elimination. Liver Int. 40, 61–66 (2020).

    PubMed 
    Article 

    Google Scholar
     

  • 138.

    Yu, M. L. et al. 2020 Taiwan consensus statement on the management of hepatitis C: part (II) special populations. J. Formos. Med. Assoc. 119, 1135–1157 (2020).

    PubMed 
    Article 

    Google Scholar
     

  • 139.

    Yang, L. et al. Effect of hepatitis C virus infection on the outcomes of in vitro fertilization. Int. J. Clin. Exp. Med. 8, 6230–6235 (2015).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 140.

    Post, J. J. Update on hepatitis C and implications for pregnancy. Obstet. Med. 10, 157–160 (2017).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 141.

    Shaw-Jackson, C. et al. In vitro fertilization for women infected by hepatitis C virus: a matched case-control study and a systematic literature review. J. Assist. Reprod. Genet. 34, 587–597 (2017).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 142.

    Money, D. et al. Obstetrical and neonatal outcomes among women infected with hepatitis C and their infants. J. Obstet. Gynaecol. Can. 36, 785–794 (2014).

    PubMed 
    Article 

    Google Scholar
     

  • 143.

    Huang, Q. T. et al. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies. J. Viral Hepat. 22, 1033–1042 (2015).

    PubMed 
    Article 

    Google Scholar
     

  • 144.

    Rezk, M. & Omar, Z. Deleterious impact of maternal hepatitis-C viral infection on maternal and fetal outcome: a 5-year prospective study. Arch. Gynecol. Obstet. 296, 1097–1102 (2017).

    PubMed 
    Article 

    Google Scholar
     

  • 145.

    Belay, T. et al. Intrahepatic cholestasis of pregnancy with concomitant hepatitis C virus infection, Joan C. Edwards SOM, Marshall University. Eur. J. Gastroenterol. Hepatol. 27, 372–374 (2015).

    PubMed 
    Article 

    Google Scholar
     

  • 146.

    Wijarnpreecha, K. et al. Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clin. Res. Hepatol. Gastroenterol. 41, 39–45 (2017).

    PubMed 
    Article 

    Google Scholar
     

  • 147.

    Kushner, T. & Terrault, N. A. Hepatitis C in pregnancy: a unique opportunity to improve the hepatitis C cascade of care. Hepatol. Commun. 3, 20–28 (2019).

    PubMed 
    Article 

    Google Scholar
     

  • 148.

    Conte, D. et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31, 751–755 (2000).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 149.

    Benova, L. et al. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin. Infect. Dis. 59, 765–773 (2014).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 150.

    Mok, J. et al. When does mother to child transmission of hepatitis C virus occur? Arch. Dis. Child. Fetal Neonatal Ed. 90, F156–F160 (2005).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 151.

    Cottrell, E. B. et al. Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 158, 109–113 (2013).

    PubMed 
    Article 

    Google Scholar
     

  • 152.

    Freriksen, J. J. M. et al. Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation – implications for maternal dosing, foetal exposure, and safety for mother and child. Aliment. Pharmacol. Ther. 50, 738–750 (2019).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 153.

    Chappell C. A. et al. A phase 1 study of ledipasvir/sofosbuvir in pregnant women with hepatitis C virus [abstract 87]. Presented at the Conference on Retroviruses and Opportunistic Infections (2019).

  • 154.

    El-Sayed, M. et al. THU-137-DAA therapy in women of child bearing age: accidental conception during therapy and pregnancy outcome [abstract]. J. Hepatol. 70, e221 (2019).


    Google Scholar
     

  • 155.

    El-Sayed, M. H.& Indolfi, G. Hepatitis C virus treatment in children: a challenge for hepatitis C virus elimination. Semin. Liver Dis. 40, 213–224 (2020).

    PubMed 
    Article 

    Google Scholar
     

  • 156.

    Indolfi, G. et al. Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol. Hepatol. 4, 477–487 (2019).

    PubMed 
    Article 

    Google Scholar
     

  • 157.

    Dahl, E. H. et al. Leaving no one behind: towards equitable global elimination of hepatitis C. J. Glob. Health 10, 010308 (2020).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 158.

    Kushner, T. et al. Evaluating women’s preferences for hepatitis C treatment during pregnancy. Hepatol. Commun. 2, 1306–1310 (2018).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 159.

    Gagnon, A. et al. Prenatal invasive procedures in women with hepatitis B, hepatitis C, and/or human immunodeficiency virus infections. J. Obstet. Gynaecol. Can. 36, 648–653 (2014).

    PubMed 
    Article 

    Google Scholar
     

  • 160.

    Garcia-Tejedor, A. et al. Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers. Eur. J. Obstet. Gynecol. Reprod. Biol. 194, 173–177 (2015).

    PubMed 
    Article 

    Google Scholar
     

  • 161.

    Mast, E. E. et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J. Infect. Dis. 192, 1880–1889 (2005).

    PubMed 
    Article 

    Google Scholar
     

  • 162.

    Polywka, S. et al. Low risk of vertical transmission of hepatitis C virus by breast milk. Clin. Infect. Dis. 29, 1327–1329 (1999).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 163.

    Zimmermann, R. et al. Hepatitis C virus in breast milk. Lancet 345, 928 (1995).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 164.

    European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. BJOG 108, 371–377 (2001).

    Article 

    Google Scholar
     

  • 165.

    Pfaender, S. et al. Inactivation of hepatitis C virus infectivity by human breast milk. J. Infect. Dis. 208, 1943–1952 (2013).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 166.

    Hillemanns, P. et al. Obstetric risks and vertical transmission of hepatitis C virus infection in pregnancy. Acta Obstet. Gynecol. Scand. 79, 543–547 (2000).

    CAS 
    PubMed 

    Google Scholar
     

  • 167.

    Bal, A. & Petrova, A. Single clinical practice’s report of testing initiation, antibody clearance, and transmission of hepatitis C virus (HCV) in infants of chronically HCV-infected mothers. Open Forum Infect. Dis. 3, ofw021 (2016).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 168.

    Polywka, S. et al. Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J. Med. Virol. 78, 305–310 (2006).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 169.

    Mack, C. L. et al. NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents. J. Pediatric Gastroenterol. Nutr. 54, 838–855 (2012).

    Article 

    Google Scholar
     

  • 170.

    Gross, M. S., Ruth, A. R. & Rasmussen, S. A. Respect women, promote health and reduce stigma: ethical arguments for universal hepatitis C screening in pregnancy. J. Med. Ethics 46, 674–677 (2020).

    PubMed 
    Article 

    Google Scholar
     

  • 171.

    US Preventive Services Task Force. Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement. JAMA 322, 349–354 (2019).

    Article 

    Google Scholar
     

  • 172.

    Chappell, C. A. et al. Hepatitis C virus screening among children exposed during pregnancy. Pediatrics 141, e20173273 (2018).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 173.

    Kuncio, D. E. et al. Failure to test and identify perinatally infected children born to hepatitis C virus-infected women. Clin. Infect. Dis. 62, 980–985 (2016).

    PubMed 
    Article 

    Google Scholar
     

  • 174.

    Alvarado-Mora, M. V. et al. An update on HDV: virology, pathogenesis and treatment. Antivir. Ther. 18, 541–548 (2013).

    PubMed 
    Article 

    Google Scholar
     

  • 175.

    Stockdale, A. J. et al. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J. Hepatol. 73, 523–532 (2020).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 176.

    Chen, H. Y. et al. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut 66, 381–382 (2018).


    Google Scholar
     

  • 177.

    Mansour, W. et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J. Med. Virol. 84, 1186–1198 (2012).

    PubMed 
    Article 

    Google Scholar
     

  • 178.

    Aftab, M. et al. Characterization of hepatitis delta virus among pregnant women of Pakistan. Viral Immunol. 32, 335–340 (2019).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 179.

    Chen, X. et al. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians. Hepatology 66, 1739–1749 (2017).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 180.

    Hughes, S. A., Wedemeyer, H. & Harrison, P. M. Hepatitis delta virus. Lancet 378, 73–85 (2011).

    PubMed 
    Article 

    Google Scholar
     

  • 181.

    Hagstrom, H. et al. Outcomes of pregnancy in mothers with cirrhosis: a national population-based cohort study of 1.3 million pregnancies. Hepatol. Commun. 2, 1299–1305 (2018).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • 182.

    Sellier, P. O. et al. Hepatitis B virus-hepatitis D virus mother-to-child co-transmission: a retrospective study in a developed country. Liver Int. 38, 611–618 (2018).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 183.

    Dusheiko, G. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues. Liver Int. 33, 137–150 (2013).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 184.

    Aggarwal, R. Diagnosis of hepatitis E. Nat. Rev. Gastroenterol. Hepatol. 10, 24–33 (2013).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 185.

    Li, R. C. et al. Seroprevalence of hepatitis E virus infection, rural southern People’s Republic of China. Emerg. Infect. Dis. 12, 1682–1688 (2006).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 186.

    Khuroo, M. S., Khuroo, M. S. & Khuroo, N. S. Transmission of hepatitis E virus in developing countries. Viruses 8, 253 (2016).

    PubMed Central 
    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • 187.

    Debing, Y. et al. Update on hepatitis E virology: implications for clinical practice. J. Hepatol. 65, 200–212 (2016).

    PubMed 
    Article 

    Google Scholar
     

  • 188.

    Dagnew, M. et al. Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis. BMC Infect. Dis. 19, 519 (2019).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 189.

    Bisayher, S. et al. Seroprevalence and risk factors of hepatitis E among women of childbearing age in the Xieng Khouang province (Lao People’s Democratic Republic), a cross-sectional survey. J. Viral Hepat. 113, 298–304 (2019).


    Google Scholar
     

  • 190.

    Li, P. et al. The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis. Liver Int. 40, 1516–1528 (2020).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 191.

    Aggarwal, R. Hepatitis E: clinical presentation in disease-endemic areas and diagnosis. Semin. Liver Dis. 33, 30–40. (2013).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 192.

    Berglov, A., Hallager, S. & Weis, N. Hepatitis E during pregnancy: maternal and foetal case-fatality rates and adverse outcomes–a systematic review. J. Viral Hepat. 26, 1240–1248 (2019).

    Article 

    Google Scholar
     

  • 193.

    Khuroo, M. S. & Kamili, S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J. Viral Hepat. 10, 61–69 (2003).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 194.

    Zhuang, H., Cao, X. Y., Liu, C. B. & Wang, G. M. Epidemiology of hepatitis E in China. Gastroenterol. Jpn. 26 (Suppl. 3), 135–138 (1991).

    PubMed 
    Article 

    Google Scholar
     

  • 195.

    Li, M. et al. Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China. J. Matern. Fetal Neonatal. Med. 33, 3647–3651 (2020).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 196.

    El Sayed Zaki, M., El Razek, M. M. A. & El Razek, H. M. A. Maternal-fetal hepatitis E transmission: is it underestimated? J. Clin. Transl. Hepatol. 2, 117–123 (2014).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 197.

    Kamar, N. et al. Hepatitis E virus infection. Clin. Microbiol. Rev. 27, 116–138 (2014).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • 198.

    Gouilly, J. et al. Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface. Nat. Commun. 9, 4748 (2018).

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • 199.

    Knegendorf, L. et al. Hepatitis E virus replication and interferon responses in human placental cells. Hepatol. Commun. 2, 173–187 (2018).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 200.

    Gad, Y. Z. et al. Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt. Asian J. Transfus. Sci. 5, 136–139 (2011).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 201.

    Yang, C. et al. Increased oestradiol in hepatitis E virus-infected pregnant women promotes viral replication. J. Viral Hepat. 25, 742–751 (2018).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 202.

    Kumar, A. et al. Impact of maternal nutrition in hepatitis E infection in pregnancy. Arch. Gynecol. Obstet. 296, 885–895 (2017).

    PubMed 
    Article 

    Google Scholar
     

  • 203.

    Rein, D. B. et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 55, 988–997 (2012).

    PubMed 
    Article 

    Google Scholar
     

  • 204.

    Gurley, E. S. et al. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection. Am. J. Public Health 102, 2248–2254 (2012).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 205.

    Sharma, S. et al. Risk factors for vertical transmission of hepatitis E virus infection. J. Viral Hepat. 24, 1067–1075 (2017).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 206.

    Nishiyama, T. et al. Screening of novel drugs for inhibiting hepatitis E virus replication. J. Virol. Methods 270, 1–11 (2019).

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 207.

    Bertuzzo, V. R. et al. Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus. Transpl. Int. 27, e87–e89 (2014).

    PubMed 
    Article 

    Google Scholar
     

  • 208.

    Li, S. W. et al. The development of a recombinant hepatitis E vaccine HEV 239. Hum. Vaccin. Immunother. 11, 908–914 (2015).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 209.

    Cao, Y. et al. Development of new hepatitis E vaccines. Hum. Vaccin. Immunother. 14, 2254–2262 (2018).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 210.

    Zaman, K. et al. HEV study protocol: design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. BMJ Open 10, e033702 (2020).

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 211.

    Zhao, Y. et al. A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions. Hum. Vaccin. Immunother. 12, 2003–2009 (2016).

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Source Link

    Related Articles

    Leave a Comment

    This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More

    %d bloggers like this: